More recently, a 2024 small pilot study of BPC for inertial cystitis showed some promise
Endocrinology (1994) 134(5):204450.10.1210/endo.134.5.7512496 236 FichterMMPirkeKMHolsboerF
This man may benefit from smoking cessation and/or antioxidant supplements
Researched applications In the published preclinical and clinical literature the effects of Cagrilintide are documented in the following areas: Obesity (stand-alone) , Phase 2 data (Lau 2021, 10.8 % at 4.5 mg) Obesity + Semaglutide (CagriSema) , Phase 3 REDEFINE 1 (25.3 %) T2DM + obesity , Phase 3 REDEFINE 2 Cardiovascular prevention , Phase 3 REDEFINE 3 (n ~ 7000) MASLD/MASH , exploratory in Phase 2 Type 2 diabetes (monotherapy) , preclinical data Prediabetes , exploratory plans Science & studies 4.1 Key publications Lau D.C.W., Erichsen L., Francisco A.M., et al
Research into these temporal dynamics of signaling is ongoing and may reveal important insights into how growth factor signaling patterns influence cellular responses
the combined-stack literature is smaller but growing
